SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12-13, 2017, Royal Society, London, UK.

Dalgleish, AG (2018) The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12-13, 2017, Royal Society, London, UK. Cancer Immunol Immunother, 67 (5). pp. 855-860. ISSN 1432-0851 https://doi.org/10.1007/s00262-018-2137-9
SGUL Authors: Dalgleish, Angus George

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (910kB) | Preview
Item Type: Article
Additional Information: © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Chemotherapy, Cyclophosphamide, Immunotherapy, Symposium, Vaccines, Immunology, 1107 Immunology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Cancer Immunol Immunother
ISSN: 1432-0851
Language: eng
Dates:
DateEvent
May 2018Published
2 March 2018Published Online
20 February 2018Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 29500634
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/109678
Publisher's version: https://doi.org/10.1007/s00262-018-2137-9

Actions (login required)

Edit Item Edit Item